Home
Exeltis Usa, Inc

Exeltis Usa, Inc Market Share Analysis for June 2026

at exeltis, we’re focused and fearless, going above and beyond to deliver better health options to our patients. we insist on—and deliver—extraordinary in everything we do.

Health > Biotechnology and Pharmaceuticals

Domainexeltisusa.com

Year Founded--

Employees51 - 200

Annual Revenue--

Exeltis Usa, Inc

Exeltis Usa, Inc (including company regionals)

exeltisusa.com

See more website traffic and engagement information

Total visits to Exeltis Usa, Inc's top domains

Understand Exeltis Usa, Inc market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

exeltisusa.com3.5K

See more with Sales Intelligence

Avg. visit duration in Exeltis Usa, Inc's top domains

Analyze Exeltis Usa, Inc engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

exeltisusa.com00:00:45

See more with Sales Intelligence

Avg. pageviews on Exeltis Usa, Inc's top domains

See how Exeltis Usa, Inc keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

exeltisusa.com2.15

See more with Sales Intelligence

Exeltis Usa, Inc top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Exeltis Usa, Inc

These are the website technologies, by industry, used by Exeltis Usa, Inc top domains

Widget (8)

Twemoji

Content Management System (4)

WordPress

Advertising (3)

DoubleClick

eCommerce (2)

WooCommerce

More Technologies

8

See all

News & Signals from Exeltis Usa, Inc

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsExeltis USA, Inc. sold assets to Alembic Therapeutics LLC on Jun 9th '26.Alembic Therapeutics, LLC announces acquisition of NUVESSA(R)(metronidazole vaginal gel 1.3%) from Exeltis USA, Inc.

NewsAgile Therapeutics, Inc. partners with Exeltis USA, Inc..Agile Therapeutics has combined with Insud Pharma's US Subsidiary, Exeltis USA, Inc., expanding an already significant women's health/contraceptive portfolio

NewsExeltis USA, Inc. launches Let's Love Every Body.FLORHAM PARK, N.J., May 08, 2024-(BUSINESS WIRE)-Exeltis USA, Inc., a division of the global pharmaceutical group Insud Pharma, today announced "Let's Love Every Body," a national campaign designed to empower women to live life to the fullest while loving and accepting their bodies.